查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲生物製造病毒檢測與定量市場：分析與預測（2023-2032）
市場調查報告書
商品編碼
1389578

歐洲生物製造病毒檢測與定量市場：分析與預測（2023-2032）

Europe Biomanufacturing Viral Detection and Quantification Market - Analysis and Forecast, 2023-2032
出版日期: | 出版商: BIS Research | 英文 81 Pages | 商品交期: 1-5個工作天內

價格

2022年，歐洲生物製造病毒檢測和定量市場規模為1.373億美元。

預計到2032年，市場規模將達到 3.459 億美元，2023-2032年預測期間年複合成長率為 9.80%。生物製藥的擴大使用和病毒檢測技術的改進預計將推動歐洲生物製造病毒檢測和定量市場的成長。

主要市場統計資料
預測期 2023-2032
2023年評估 1.492 億美元
2032年預測 3.459 億美元
年複合成長率 9.8%

由於生物製藥的使用不斷增加，歐洲生物製造病毒檢測和定量市場迅速擴大。隨著生技藥品需求的增加，確保這些產品的安全性、有效性和一致性變得越來越重要。需要健全的品管程序來遵守法規並維持產品完整性。其中一種程序是生物製造過程中病毒污染的測定。因此，歐洲生物製造病毒檢測和定量市場對消耗品和設備的需求激增。隨著技術的進步和對維持高標準的承諾，市場已為該領域的持續成長做好了準備。

本報告研究了歐洲生物製造病毒檢測和定量市場，提供市場概述，按產品類型、技術、應用、最終用戶、國家的趨勢，和參與市場的公司概況等。

目錄

第1章 產品定義

第2章 市場範圍

第3章 調查方法

第4章 歐洲

  • 概述
  • 歐洲
    • 歐洲生物製造病毒檢測和定量市場（依產品類型）
    • 歐洲生物製造病毒檢測和定量市場（依技術）
    • 歐洲生物製造病毒檢測和定量市場（依應用）
    • 歐洲生物製造病毒檢測和定量市場（依最終用戶）
    • 歐洲生物製造病毒檢測和定量市場（依國家）

第5章 市場－競爭基準化分析與公司概況

  • 概述
  • 企業市場占有率分析
  • 生物製造病毒檢測和定量市場的參與企業
  • Merck KGaA
  • Sartorius AG
  • QIAGEN NV
Product Code: BHL1567SS

“The Europe Biomanufacturing Viral Detection and Quantification Market Expected to Reach $345.9 Million by 2032.”

Introduction to Europe Biomanufacturing Viral Detection and Quantification Market

The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$149.2 Million
2032 Forecast$345.9 Million
CAGR9.8%

The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.

Market Segmentation:

Segmentation 1: by Offering Type

  • Consumables
  • Instruments
  • Services

Segmentation 2: by Technology

  • PCR
  • ELISA
  • Flow Cytometry
  • Plaque Assay
  • Others

Segmentation 3: by Application

  • Blood and Blood Products Manufacturing
  • Vaccines and Therapeutics Manufacturing
  • Cellular and Gene Therapy Products Manufacturing
  • Stem Cell Products Manufacturing
  • Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

  • Life Science Companies
  • Testing Laboratories
  • CROs and CDMOs

Segmentation 6: by Country

  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

  • Merck KGaA
  • Sartorius AG
  • QIAGEN N.V.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion Criteria

2 Market Scope

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

4 Europe

  • 4.1 Overview
  • 4.2 Europe
    • 4.2.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 4.2.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 4.2.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 4.2.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 4.2.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
      • 4.2.5.1 Germany
        • 4.2.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 4.2.5.2 U.K.
        • 4.2.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 4.2.5.3 France
        • 4.2.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 4.2.5.4 Spain
        • 4.2.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 4.2.5.5 Italy
        • 4.2.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 4.2.5.6 Rest-of-Europe
        • 4.2.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 4.2.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 4.2.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 4.2.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Overview
  • 5.2 Company Share Analysis
  • 5.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
  • 5.4 Merck KGaA
    • 5.4.1 Company Overview
    • 5.4.2 Role of Merck KGaA in the Biomanufacturing Viral Detection and Quantification Market
    • 5.4.3 Key Competitors
    • 5.4.4 Financials
    • 5.4.5 Key Insights about the Financial Health of the Company
    • 5.4.6 Analyst Perspective
  • 5.5 Sartorius AG
    • 5.5.1 Company Overview
    • 5.5.2 Role of Sartorius AG in the Biomanufacturing Viral Detection and Quantification Market
    • 5.5.3 Key Competitors
    • 5.5.4 Financials
    • 5.5.5 Analyst Perspective
  • 5.6 QIAGEN N.V.
    • 5.6.1 Company Overview
    • 5.6.2 Role of QIAGEN N.V. in the Biomanufacturing Viral Detection and Quantification Market
    • 5.6.3 Key Competitors
    • 5.6.4 Financials
    • 5.6.5 Key Insights about the Financial Health of the Company
    • 5.6.6 Analyst Perspective

List of Figures

  • Figure 1: Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 2: Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
  • Figure 3: Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
  • Figure 4: Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
  • Figure 5: Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
  • Figure 6: Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
  • Figure 7: Biomanufacturing Viral Detection and Quantification Market: Research Methodology
  • Figure 8: Primary Research Methodology
  • Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 10: Top-Down Approach (Segment-Wise Analysis)
  • Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
  • Figure 12: Europe: Market Dynamics
  • Figure 13: Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 14: Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 15: Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 16: Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 17: Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 18: Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 19: Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 20: Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 21: Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 22: Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 23: U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 24: U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 25: U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 26: U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 27: U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 28: France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 29: France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 30: France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 31: France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 32: France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 33: Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 34: Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 35: Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 36: Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 37: Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 38: Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 39: Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 40: Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 41: Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 42: Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 43: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 44: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 45: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 46: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 47: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 48: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
  • Figure 49: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
  • Figure 50: Merck KGaA: Product Portfolio
  • Figure 51: Merck KGaA: Overall Financials, $Million, 2020-2022
  • Figure 52: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
  • Figure 53: Merck KGaA: Revenue (by Region), $Million, 2020-2022
  • Figure 54: Merck KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 55: Sartorius AG: Product Portfolio
  • Figure 56: Sartorius AG: Overall Financials, $Million, 2020-2022
  • Figure 57: Sartorius AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 58: Sartorius AG: Revenue (by Region), $Million, 2020-2022
  • Figure 59: QIAGEN N.V.: Product Portfolio
  • Figure 60: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
  • Figure 61: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
  • Figure 62: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
  • Figure 63: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
  • Table 2: Key Questions Answered in the Report